Losmapimod, a novel p38 mitogen-activated protein kinase inhibitor, in non-ST-segment elevation myocardial infarction: A randomised phase 2 trial.
Times cited: 56
The Study of LoSmapimod treatment on inflammation and InfarCtSizE (SOLSTICE): Design and rationale.
American Heart Journal.
Times cited: 18